Metastatic Melanoma

Nearly one million Americans have melanoma and 9,940 will die of the disease in 2015. With poor patient outcomes and no known cure for metastatic melanoma, the unmet need for effective therapies is significant.


Precision Medicine

Our lead product, SRX-1177, creates a new class of melanoma therapy, combining a novel peptide with a commercially available radioisotope into an injectable drug. Similar radiotherapies for other cancers are effective in up to 75% of patients.


Company Profile

SolaranRx is developing a platform of therapies and companion imaging agents for metastatic melanoma, representing a game changer for both clinicians and patients.


Skin in the Game Blog

Bob Marley, Melanoma and You


Upcoming Events

There are no upcoming events.

News + Events

SolaranRx Signs Research Agreement with the National Cancer Institute to Advance Metastatic Melanoma Theranostic